Paul Allen has pledged $30 million to help house homeless families in Seattle, as the city grapples with an ongoing crisis and debates how to pay for it.
With an additional $5 million in capital from city coffers, the funding from... Read more »
Founding Director, Massachusetts Technology Transfer Center
CEO and Fund Manager, Renaissance Venture Capital Fund
Professor of Systems Biology, Columbia University
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Earlier this month, the Michigan State University-backed Conquer accelerator program announced the five startups that will spend the summer pushing their products and technologies to market.
Starting in June, Conquer participants will begin the 10-week incubation program. What makes Conquer different... Read more »
Arsanis, a Waltham, MA-based biotech co-founded by scientist and entrepreneur Tillman Gerngross to develop treatments for bacterial and viral infections, has raised a $45.5 million investment led by the Bill & Melinda Gates Foundation to finance a mid-stage clinical trial for... Read more »
Catch up on news from Wisconsin’s innovation community, starting with these recent headlines:
The Indianapolis-based startup Greenlight.guru, maker of quality management software for organizations in the medical device industry, plans to invest $651,022 in a new, 7,200-square-foot office at Union 525, a tech hub in the city’s downtown. The new office is... Read more »
One reason that drug-resistant “superbugs” are a growing healthcare problem is the hardiness of gram-negative bacteria, a type of bacteria whose characteristics render many antibiotics ineffective. Forge Therapeutics says it has found a way to target an enzyme found only in... Read more »
Cellular Dynamics International, a Madison, WI-based manufacturer of human cells, recently signed a collaboration agreement with the Harvard Stem Cell Institute that’s aimed at making greater quantities of stem cells available to researchers at the institute and its affiliates.
CDI... Read more »
After seeing its two most advanced cancer therapies fail in clinical trials this month, OncoMed Pharmaceuticals is slashing its workforce by half and focusing on compounds in earlier stages of development, the company announced Monday.
The layoffs will leave Redwood City,... Read more »
This week, we’re looking forward to Saturday’s March for Science and back at Microsoft’s acquisition of Charles Simonyi’s Intentional Software; former Microsoft CEO Steve Ballmer’s new effort to inject facts into debate about government; potential changes to the high-skilled visa program... Read more »
Voice-controlled virtual assistants, virtual reality, and artificial intelligence technologies could all reshape the healthcare industry in the coming years, but forming strong relationships between patients and doctors will be more important than ever.
That was a key takeaway from a panel... Read more »
Dallas—In addition to founding tech startups such as mobile e-retail company Appconomy, entrepreneur Steve Guengerich has simultaneously focused on teaching young entrepreneurs and taking on roles that can help build an innovation ecosystem during his years in Austin.
So it’s... Read more »
A technology that delivers drugs across the blood-brain barrier. A medical device developed to diagnose sepsis. And a potential new treatment for radiation contamination during a disaster. These were some of the technologies on display Wednesday evening at the Innovation Showcase,... Read more »
In 2014, Plymouth, MI-based biotech startup Tissue Regeneration Systems (TRS) began collaborating with DePuy Synthes Products, a company under the Johnson & Johnson umbrella making orthopedic products, such as the devices used in joint replacements.
This week, DePuy formalized that... Read more »
Nobel Laureate David Baltimore. Microbiome AND supercomputer pioneer Larry Smarr. Intellectual Ventures’ Nathan Myhrvold. Nicole Glaros of Techstars.
These are just a few of the visionary speakers who will be headlining Xconomy’s sixth annual Napa Summit. And if you act... Read more »
Managing Director, DaggerBoard Advisors
CEO of the Marine Bio-Technologies Center of Innovation
Founder and Managing Partner, Frazier Healthcare Ventures
Visiting Scholar, University of Southern California
Nobel Laureate, Professor of Biology, Caltech